- Report
- September 2022
- 123 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- August 2022
- 85 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- June 2022
- 91 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- April 2022
- 77 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- January 2022
- 98 Pages
Global
From €3200EUR$3,842USD£2,920GBP
- Report
- January 2022
- 92 Pages
Global
From €3200EUR$3,842USD£2,920GBP
- Report
- November 2025
Global
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Global
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
United States
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
North America
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Europe
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Middle East
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Asia Pacific
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
United States
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
United Kingdom
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
North America
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Europe
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Middle East
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
Asia Pacific
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP
- Report
- November 2025
China
From €1869EUR$2,095USD£1,648GBP
€3560EUR$3,990USD£3,139GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more